Literature DB >> 24045557

Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas.

Mark A Samols1, Nathan E Smith, Jonathan M Gerber, Milena Vuica-Ross, Christopher D Gocke, Kathleen H Burns, Michael J Borowitz, Toby C Cornish, Amy S Duffield.   

Abstract

OBJECTIVES: To examine the accuracy of software-assisted measurement of the Ki-67 proliferation index (PI) and its correlation with the grade and clinical progression of follicular lymphoma (FL).
METHODS: High-power field equivalents were extracted from H&E- and Ki-67-immunostained slides of FL, and a nuclear quantitation algorithm was used to calculate a PI. Representative fields were manually counted for validation with close agreement.
RESULTS: The PI was significantly higher in World Health Organization grade 3 FL than grade 1 to 2 FL. Disease progression, as defined by subsequent treatment with radiation or cytotoxic chemotherapy, was also significantly associated with elevated PI but not pathologic grade.
CONCLUSIONS: These data show that software-automated quantitation of Ki-67 can provide both a useful adjunct to pathologic grade in FL and improved prognostic information for patients.

Entities:  

Keywords:  Automated counting; Follicular lymphoma; Histologic grade; Ki-67; Proliferation index; Quantitation

Mesh:

Substances:

Year:  2013        PMID: 24045557      PMCID: PMC4010253          DOI: 10.1309/AJCPTMA1F6LWYTQV

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  27 in total

1.  Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders.

Authors:  R J Bryant; P M Banks; D P O'Malley
Journal:  Histopathology       Date:  2006-04       Impact factor: 5.087

2.  HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques.

Authors:  C M Ellis; M J Dyson; T J Stephenson; E L Maltby
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

3.  Automated quantification of nuclear immunohistochemical markers with different complexity.

Authors:  Carlos López; Marylène Lejeune; María Teresa Salvadó; Patricia Escrivà; Ramón Bosch; Lluis E Pons; Tomás Alvaro; Jordi Roig; Xavier Cugat; Jordi Baucells; Joaquín Jaén
Journal:  Histochem Cell Biol       Date:  2008-01-03       Impact factor: 4.304

Review 4.  Follicular Lymphoma International Prognostic Index.

Authors:  Philippe Solal-Celigny
Journal:  Curr Treat Options Oncol       Date:  2006-07

5.  Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.

Authors:  Björn E Wahlin; Olav E Yri; Eva Kimby; Harald Holte; Jan Delabie; Erlend B Smeland; Christer Sundström; Birger Christensson; Birgitta Sander
Journal:  Br J Haematol       Date:  2011-11-30       Impact factor: 6.998

6.  Utility of SKP2 and MIB-1 in grading follicular lymphoma using quantitative imaging analysis.

Authors:  Kai Zhang; Jeffrey W Prichard; Shawn Yoder; Jitakshi De; Fan Lin
Journal:  Hum Pathol       Date:  2007-03-12       Impact factor: 3.466

7.  Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma.

Authors:  Sverker Hasselblom; Borje Ridell; Margret Sigurdardottir; Ulrika Hansson; Herman Nilsson-Ehle; Per-Ola Andersson
Journal:  Leuk Lymphoma       Date:  2008-08

8.  Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma.

Authors:  Sumita Gokhale; Daniel Rosen; Nour Sneige; Leslie K Diaz; Erika Resetkova; Aysegul Sahin; Jinsong Liu; Constance T Albarracin
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-12

9.  Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry.

Authors:  Antonio E Martinez; Li Lin; Cherie H Dunphy
Journal:  Arch Pathol Lab Med       Date:  2007-07       Impact factor: 5.534

10.  Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.

Authors:  G M Sharangpani; A S Joshi; K Porter; A S Deshpande; S Keyhani; G A Naik; A S Gholap; S H Barsky
Journal:  J Microsc       Date:  2007-06       Impact factor: 1.758

View more
  3 in total

1.  Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.

Authors:  Rafael Duran; Sahar Mirpour; Vasily Pekurovsky; Shanmugasundaram Ganapathy-Kanniappan; Cory F Brayton; Toby C Cornish; Boris Gorodetski; Juvenal Reyes; Julius Chapiro; Rüdiger E Schernthaner; Constantine Frangakis; MingDe Lin; Jessica D Sun; Charles P Hart; Jean-François Geschwind
Journal:  Clin Cancer Res       Date:  2016-07-20       Impact factor: 12.531

2.  Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.

Authors:  Aliyah R Sohani; Matthew J Maurer; Sharmila Giri; Brandelyn Pitcher; Amy Chadburn; Jonathan W Said; Nancy L Bartlett; Myron S Czuczman; Peter Martin; Cara A Rosenbaum; Sin-Ho Jung; John P Leonard; Bruce D Cheson; Eric D Hsi
Journal:  Am J Surg Pathol       Date:  2021-03-01       Impact factor: 6.298

3.  Bidirectional Mapping-Based Domain Adaptation for Nucleus Detection in Cross-Modality Microscopy Images.

Authors:  Fuyong Xing; Toby C Cornish; Tellen D Bennett; Debashis Ghosh
Journal:  IEEE Trans Med Imaging       Date:  2021-09-30       Impact factor: 11.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.